位置:首页 > 蛋白库 > SUMO1_MOUSE
SUMO1_MOUSE
ID   SUMO1_MOUSE             Reviewed;         101 AA.
AC   P63166; P55856; Q3TX92; Q93068;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2004, sequence version 1.
DT   03-AUG-2022, entry version 169.
DE   RecName: Full=Small ubiquitin-related modifier 1;
DE            Short=SUMO-1;
DE   AltName: Full=SMT3 homolog 3;
DE   AltName: Full=Ubiquitin-homology domain protein PIC1;
DE   AltName: Full=Ubiquitin-like protein SMT3C;
DE            Short=Smt3C;
DE   Flags: Precursor;
GN   Name=Sumo1; Synonyms=Smt3c, Smt3h3, Ubl1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=ICR;
RX   PubMed=9465300; DOI=10.1006/geno.1997.5091;
RA   Howe K., Williamson J., Boddy M.N., Sheer D., Freemont P.S., Solomon E.;
RT   "The ubiquitin-homology gene PIC1: characterization of mouse (Pic1) and
RT   human (UBL1) genes and pseudogenes.";
RL   Genomics 47:92-100(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Kidney, Liver, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, INDUCTION, AND INTERACTION WITH HIF1A.
RX   PubMed=15225651; DOI=10.1016/j.febslet.2004.05.079;
RA   Shao R., Zhang F.-P., Tian F., Anders Friberg P., Wang X., Sjoeland H.,
RA   Billig H.;
RT   "Increase of SUMO-1 expression in response to hypoxia: direct interaction
RT   with HIF-1alpha in adult mouse brain and heart in vivo.";
RL   FEBS Lett. 569:293-300(2004).
RN   [5]
RP   INTERACTION WITH IKFZ1.
RX   PubMed=15767674; DOI=10.1128/mcb.25.7.2688-2697.2005;
RA   Gomez-del Arco P., Koipally J., Georgopoulos K.;
RT   "Ikaros SUMOylation: switching out of repression.";
RL   Mol. Cell. Biol. 25:2688-2697(2005).
RN   [6]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16990542; DOI=10.1126/science.1128406;
RA   Alkuraya F.S., Saadi I., Lund J.J., Turbe-Doan A., Morton C.C., Maas R.L.;
RT   "SUMO1 haploinsufficiency leads to cleft lip and palate.";
RL   Science 313:1751-1751(2006).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18681895; DOI=10.1111/j.1365-2443.2008.01216.x;
RA   Kuwata T., Nakamura T.;
RT   "BCL11A is a SUMOylated protein and recruits SUMO-conjugation enzymes in
RT   its nuclear body.";
RL   Genes Cells 13:931-940(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.m800451-mcp200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of electron
RT   capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [9]
RP   INTERACTION WITH HINT1.
RX   PubMed=31088288; DOI=10.1089/ars.2019.7724;
RA   Cortes-Montero E., Rodriguez-Munoz M., Sanchez-Blazquez P., Garzon J.;
RT   "The Axonal Motor Neuropathy-Related HINT1 Protein Is a Zinc- and
RT   Calmodulin-Regulated Cysteine SUMO Protease.";
RL   Antioxid. Redox Signal. 31:503-520(2019).
CC   -!- FUNCTION: Ubiquitin-like protein that can be covalently attached to
CC       proteins as a monomer or a lysine-linked polymer. Covalent attachment
CC       via an isopeptide bond to its substrates requires prior activation by
CC       the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be
CC       promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-
CC       translational modification on lysine residues of proteins plays a
CC       crucial role in a number of cellular processes such as nuclear
CC       transport, DNA replication and repair, mitosis and signal transduction.
CC       Involved for instance in targeting RANGAP1 to the nuclear pore complex
CC       protein RANBP2. Covalently attached to the voltage-gated potassium
CC       channel KCNB1; this modulates the gating characteristics of KCNB1.
CC       Polymeric SUMO1 chains are also susceptible to polyubiquitination which
CC       functions as a signal for proteasomal degradation of modified proteins.
CC       May also regulate a network of genes involved in palate development.
CC       Covalently attached to ZFHX3 (By similarity).
CC       {ECO:0000250|UniProtKB:P63165, ECO:0000269|PubMed:16990542}.
CC   -!- SUBUNIT: Covalently attached to KCNB1; UBE2I increases cross-linking
CC       with KCNB1 and PIAS1 decreases cross-links with KCNB1 (By similarity).
CC       Interacts with SAE2, RANBP2, PIAS1 and PIAS2 (By similarity). Interacts
CC       with PRKN (By similarity). Covalently attached to a number of proteins
CC       such as IKFZ1, PML, RANGAP1, HIPK2, SP100, p53, p73-alpha, MDM2, JUN,
CC       DNMT3B and TDG (By similarity). Also interacts with HIF1A, HIPK2,
CC       HIPK3, CHD3, EXOSC9, RAD51 and RAD52 (By similarity). Interacts with
CC       USP25 (via ts SIM domain); the interaction weakly sumoylates USP25 (By
CC       similarity). Interacts with SIMC1, CASP8AP2, RNF111 AND SOBP (via SIM
CC       domains) (By similarity). Interacts with BHLHE40/DEC1 (By similarity).
CC       Interacts with RWDD3 (By similarity). Interacts with UBE2I/UBC9 and
CC       this interaction is enhanced in the presence of RWDD3 (By similarity).
CC       Interacts with MTA1 (By similarity). Interacts with SENP2 (By
CC       similarity). Interacts with HINT1 (PubMed:31088288).
CC       {ECO:0000250|UniProtKB:P63165, ECO:0000269|PubMed:31088288}.
CC   -!- INTERACTION:
CC       P63166; Q03267: Ikzf1; NbExp=2; IntAct=EBI-80152, EBI-908572;
CC       P63166; Q505F1: Nr2c1; NbExp=5; IntAct=EBI-80152, EBI-15617004;
CC       P63166; P63015: Pax6; NbExp=2; IntAct=EBI-80152, EBI-1395428;
CC       P63166; P26367-1: PAX6; Xeno; NbExp=2; IntAct=EBI-80152, EBI-15892945;
CC       P63166; P18031: PTPN1; Xeno; NbExp=2; IntAct=EBI-80152, EBI-968788;
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:P63165}.
CC       Nucleus speckle {ECO:0000269|PubMed:18681895}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P63165}. Nucleus, PML body
CC       {ECO:0000250|UniProtKB:P63165}. Cell membrane
CC       {ECO:0000250|UniProtKB:P63165}. Nucleus {ECO:0000250|UniProtKB:P63165}.
CC       Note=Recruited by BCL11A into the nuclear body (PubMed:18681895). In
CC       the presence of ZFHX3, sequesterd to nuclear body (NB)-like dots in the
CC       nucleus some of which overlap or closely associate with PML body (By
CC       similarity). {ECO:0000250|UniProtKB:P63165,
CC       ECO:0000269|PubMed:18681895}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DEVELOPMENTAL STAGE: Expressed at 13.5 dpc strongly in the upper lip,
CC       primary palate and medial edge epithelia of the secondary palate. At
CC       14.5 dpc expression could be seen in the medial edge epithelial seam.
CC       {ECO:0000269|PubMed:16990542}.
CC   -!- INDUCTION: By hypoxia. {ECO:0000269|PubMed:15225651}.
CC   -!- PTM: Cleavage of precursor form by SENP1 or SENP2 is necessary for
CC       function. {ECO:0000250|UniProtKB:P63165}.
CC   -!- PTM: Polymeric SUMO1 chains undergo polyubiquitination by RNF4.
CC       {ECO:0000250|UniProtKB:P63165}.
CC   -!- SIMILARITY: Belongs to the ubiquitin family. SUMO subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF033353; AAC39959.1; -; mRNA.
DR   EMBL; AK002536; BAB22172.1; -; mRNA.
DR   EMBL; AK011074; BAB27379.1; -; mRNA.
DR   EMBL; AK089081; BAC40739.1; -; mRNA.
DR   EMBL; AK159366; BAE35024.1; -; mRNA.
DR   EMBL; BC082566; AAH82566.1; -; mRNA.
DR   EMBL; BC083158; AAH83158.1; -; mRNA.
DR   CCDS; CCDS35586.1; -.
DR   RefSeq; NP_033486.1; NM_009460.2.
DR   AlphaFoldDB; P63166; -.
DR   BMRB; P63166; -.
DR   SMR; P63166; -.
DR   BioGRID; 204420; 16.
DR   CORUM; P63166; -.
DR   DIP; DIP-29278N; -.
DR   IntAct; P63166; 14.
DR   MINT; P63166; -.
DR   STRING; 10090.ENSMUSP00000088935; -.
DR   iPTMnet; P63166; -.
DR   PhosphoSitePlus; P63166; -.
DR   SwissPalm; P63166; -.
DR   EPD; P63166; -.
DR   jPOST; P63166; -.
DR   MaxQB; P63166; -.
DR   PaxDb; P63166; -.
DR   PeptideAtlas; P63166; -.
DR   PRIDE; P63166; -.
DR   ProteomicsDB; 257507; -.
DR   Antibodypedia; 3793; 1185 antibodies from 45 providers.
DR   DNASU; 22218; -.
DR   Ensembl; ENSMUST00000091374; ENSMUSP00000088935; ENSMUSG00000026021.
DR   GeneID; 22218; -.
DR   KEGG; mmu:22218; -.
DR   UCSC; uc007bdx.1; mouse.
DR   CTD; 7341; -.
DR   MGI; MGI:1197010; Sumo1.
DR   VEuPathDB; HostDB:ENSMUSG00000026021; -.
DR   eggNOG; KOG1769; Eukaryota.
DR   GeneTree; ENSGT00940000154319; -.
DR   HOGENOM; CLU_148322_0_0_1; -.
DR   InParanoid; P63166; -.
DR   OMA; TIECHIE; -.
DR   OrthoDB; 1583700at2759; -.
DR   PhylomeDB; P63166; -.
DR   TreeFam; TF315116; -.
DR   Reactome; R-MMU-3065676; SUMO is conjugated to E1 (UBA2:SAE1).
DR   Reactome; R-MMU-3065678; SUMO is transferred from E1 to E2 (UBE2I, UBC9).
DR   Reactome; R-MMU-3065679; SUMO is proteolytically processed.
DR   Reactome; R-MMU-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-MMU-3108232; SUMO E3 ligases SUMOylate target proteins.
DR   Reactome; R-MMU-3232118; SUMOylation of transcription factors.
DR   Reactome; R-MMU-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-MMU-3899300; SUMOylation of transcription cofactors.
DR   Reactome; R-MMU-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-MMU-4090294; SUMOylation of intracellular receptors.
DR   Reactome; R-MMU-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-MMU-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-MMU-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-MMU-4655427; SUMOylation of DNA methylation proteins.
DR   Reactome; R-MMU-4755510; SUMOylation of immune response proteins.
DR   Reactome; R-MMU-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-MMU-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-MMU-877312; Regulation of IFNG signaling.
DR   Reactome; R-MMU-8866904; Negative regulation of activity of TFAP2 (AP-2) family transcription factors.
DR   Reactome; R-MMU-9615933; Postmitotic nuclear pore complex (NPC) reformation.
DR   BioGRID-ORCS; 22218; 4 hits in 70 CRISPR screens.
DR   ChiTaRS; Sumo1; mouse.
DR   PRO; PR:P63166; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; P63166; protein.
DR   Bgee; ENSMUSG00000026021; Expressed in morula and 70 other tissues.
DR   ExpressionAtlas; P63166; baseline and differential.
DR   Genevisible; P63166; MM.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0001650; C:fibrillar center; ISO:MGI.
DR   GO; GO:0000792; C:heterochromatin; ISO:MGI.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; ISO:MGI.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0097165; C:nuclear stress granule; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:MGI.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:MGI.
DR   GO; GO:0001741; C:XY body; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; ISO:MGI.
DR   GO; GO:0015459; F:potassium channel regulator activity; ISS:UniProtKB.
DR   GO; GO:0031386; F:protein tag; IBA:GO_Central.
DR   GO; GO:0044388; F:small protein activating enzyme binding; ISO:MGI.
DR   GO; GO:0008134; F:transcription factor binding; IMP:AgBase.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISS:UniProtKB.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; IBA:GO_Central.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; ISO:MGI.
DR   GO; GO:0071276; P:cellular response to cadmium ion; ISS:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0045759; P:negative regulation of action potential; ISS:UniProtKB.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0043392; P:negative regulation of DNA binding; ISO:MGI.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISO:MGI.
DR   GO; GO:0042308; P:negative regulation of protein import into nucleus; ISO:MGI.
DR   GO; GO:0010621; P:negative regulation of transcription by transcription factor localization; ISO:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISO:MGI.
DR   GO; GO:0030578; P:PML body organization; IMP:MGI.
DR   GO; GO:1901896; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; IMP:BHF-UCL.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:MGI.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; ISO:MGI.
DR   GO; GO:0090204; P:protein localization to nuclear pore; IMP:MGI.
DR   GO; GO:0050821; P:protein stabilization; ISO:MGI.
DR   GO; GO:0016925; P:protein sumoylation; IDA:MGI.
DR   GO; GO:1903169; P:regulation of calcium ion transmembrane transport; IMP:BHF-UCL.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; IMP:BHF-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:BHF-UCL.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0060021; P:roof of mouth development; IMP:UniProtKB.
DR   CDD; cd16114; Ubl_SUMO1; 1.
DR   InterPro; IPR022617; Rad60/SUMO-like_dom.
DR   InterPro; IPR046332; SUMO1_Ubl.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF11976; Rad60-SLD; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Cytoplasm; Isopeptide bond; Membrane; Nucleus;
KW   Phosphoprotein; Reference proteome; Stress response; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CHAIN           2..97
FT                   /note="Small ubiquitin-related modifier 1"
FT                   /id="PRO_0000035941"
FT   PROPEP          98..101
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000035942"
FT   DOMAIN          20..97
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   SITE            36
FT                   /note="Interaction with PIAS2"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19131326"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        17
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        23
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        25
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        37
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        39
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        45
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        46
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P63165"
FT   CROSSLNK        97
FT                   /note="Glycyl lysine isopeptide (Gly-Lys) (interchain with
FT                   K-? in acceptor proteins)"
SQ   SEQUENCE   101 AA;  11557 MW;  89BE97D2D054FB33 CRC64;
     MSDQEAKPST EDLGDKKEGE YIKLKVIGQD SSEIHFKVKM TTHLKKLKES YCQRQGVPMN
     SLRFLFEGQR IADNHTPKEL GMEEEDVIEV YQEQTGGHST V
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024